eCO2
3D
Is It / For You?

A good candidate is not someone who wants CO2. A good candidate is someone whose concern, skin, history, risk profile, downtime capacity, expectations and timing make fractional CO2 resurfacing a reasonable tool. Candidacy is a match, not a desire.

RIGHT DEVICE. WRONG PATIENT. STILL THE WRONG TREATMENT.

Candidacy can be thought of as seven checks. The concern matches. The mechanism matches. The skin can be appropriately treated. The risk is acceptable. The downtime is acceptable. The expectation is realistic. The timing makes sense. All seven interact. No single factor determines candidacy alone.

CONCERN. SKIN. HISTORY. RISK. DOWNTIME. EXPECTATION. TIMING.

CO2 resurfacing addresses surface concerns: certain acne scars, texture, fine lines, photoaging. If the primary concern is not a resurfacing problem, the concern does not match. A concern match is the first question, not the last.

Fractional ablative CO2 creates controlled columns of thermal injury to stimulate remodeling. If the problem is movement, volume, laxity or vascular, the mechanism does not match. Mechanism is not preference. It is physics.

Baseline skin, phototype, PIH history, melasma, recent UV exposure and healing history all affect whether the skin can be appropriately treated. Skin assessment is individual. No universal yes or no applies to any group.

Every treatment carries risk. PIH, infection, prolonged erythema, scarring and unsatisfactory response are possible. A good candidate understands and accepts the risk profile relevant to their skin and plan. Risk tolerance is personal.

CO2 resurfacing involves visible healing. A good candidate can accommodate the recovery window, aftercare, sun avoidance and follow-up their plan requires. If downtime is not acceptable, timing or treatment may need to change.

Improvement is not elimination. Softer scars, better texture, refined lines. Not zero scars, not filtered skin, not facelift-level lifting. A realistic expectation is part of candidacy. An unrealistic one can change whether treatment is appropriate.

An upcoming wedding, vacation, beach trip, work event or photography commitment affects timing. If the recovery window conflicts with an important event, timing may not make sense right now. Timing is part of the plan.

Before discussing devices, discuss the concern. What is the specific change the patient wants? What is causing it? What can CO2 actually change? What can it not? The concern test precedes the device discussion.

WHAT ARE WE ACTUALLY TRYING TO CHANGE?

Certain acne scars may be appropriate for fractional CO2 resurfacing. Scar morphology, depth, skin type and healing history all affect candidacy. Not every scar responds the same way. Acne scar education precedes scar treatment.

Rolling scars have a broad, sloping architecture often involving tethering beneath the surface. Resurfacing may improve surface texture, but rolling scars frequently involve deeper structure. CO2 alone may not be sufficient for every rolling scar.

Boxcar scars have defined edges and a flat base. Resurfacing may address the surface and edges. Depth and edge definition influence response. Not all boxcar scars respond identically, and morphology should be assessed individually.

Ice-pick scars are narrow and deep. CO2 resurfacing alone may not be the primary approach for every ice-pick scar. Other techniques may be considered for this morphology. One device does not address every scar architecture.

Most acne-scar faces contain more than one scar type. A mixed presentation may require more than one approach over time. A single treatment plan does not address every scar morphology on the face.

ONE FACE CAN NEED MORE THAN ONE STRATEGY.

Active inflammatory acne and residual acne scarring are different treatment questions. CO2 resurfacing addresses scarring. It is not a treatment for active inflammatory acne. Treating scars while new ones are still forming may not be the right sequence.

Controlling the process creating new scars often comes before resurfacing old ones. If active acne is still producing new lesions, scar treatment may be premature. Provider assessment determines the appropriate sequence for the individual patient.

CONTROL THE PROCESS CREATING NEW SCARS BEFORE ONLY CHASING THE OLD ONES.

Fine lines may be an appropriate resurfacing concern. Lines that are superficial, static and surface-related may respond to fractional CO2. Line depth, location and skin characteristics affect candidacy. Not every line is the same problem.

Deep wrinkles involve structural contribution that resurfacing alone may not fully address. CO2 may improve surface texture and soften appearance, but deep folds often involve volume, movement or laxity. A single mechanism does not solve every layer.

Dynamic wrinkles are created by muscle movement. Resurfacing addresses surface texture. Neuromodulators address movement. They are different mechanisms for different problems. CO2 does not replace Botox or Dysport for movement-created lines.

MOVEMENT IS NOT SURFACE TEXTURE.

Crepey skin involves fine surface wrinkling often related to thinning and photoaging. Fractional resurfacing may improve surface quality in appropriately selected patients. Skin laxity, thickness and location affect whether resurfacing is the right approach.

CO2 resurfacing may improve the appearance of pores in some patients. Pores do not open and close. Resurfacing may refine surface quality around the pore, but no treatment eliminates pores. Expecting pore elimination is not a realistic expectation.

APPEARANCE OF PORES. NOT CLOSURE.

Rough texture may be an appropriate resurfacing concern. Surface irregularity, photoaging and uneven skin quality may improve with fractional CO2 in appropriately selected patients. Texture is a direction, not a single endpoint.

Photoaging includes multiple changes: pigment, texture, fine lines and surface quality. CO2 may address certain components of photoaging. Not every sun-damage finding is a resurfacing finding. The specific sun-damage concern matters.

Pigmented lesions should be appropriately assessed before treatment. Not every brown spot is the same. Sun spots, post-inflammatory pigment and melasma require different discussions. CO2 is not automatically the right approach for every pigmented concern.

Ablative CO2 is not positioned as a routine universal melasma therapy. Melasma involves complex pigment biology that may react unpredictably to inflammation. A history of melasma changes the risk-benefit discussion. This requires individualized clinical assessment.

CO2 resurfacing is not automatically the appropriate treatment for redness. Vascular concerns involve different targets and different mechanisms. Redness requires its own assessment. Resurfacing and vascular treatment are not interchangeable.

Rosacea is a distinct diagnosis. CO2 resurfacing is not an established routine treatment for rosacea. Whether resurfacing is appropriate for a patient with rosacea requires individualized clinical assessment. No unsupported indication is claimed.

Resurfacing improves surface quality. It does not reposition tissue. Skin laxity involves structural change that resurfacing alone does not address. If the primary concern is laxity, a tightening or surgical conversation may be more appropriate.

RESURFACING IS NOT LIFTING.

Jowling involves tissue descent and structural change. It is not a surface-texture problem. CO2 resurfacing does not reposition jowls. If jowling is the primary concern, a different treatment conversation is needed.

JOWLING IS NOT A SURFACE-TEXTURE PROBLEM.

Volume loss is a structural problem. Resurfacing does not restore volume. If the primary concern is hollowing, deflation or volume loss, a volume conversation is needed. CO2 does not replace filler, biostimulators or fat.

Under-eye concerns involve skin texture, fat pads, volume and laxity. CO2 may address surface quality. It does not address fat pads or structural volume. The specific under-eye concern determines the appropriate treatment conversation.

If the problem is not primarily a resurfacing problem, resurfacing may not be the primary answer. The mechanism test asks whether the concern is a surface problem, a movement problem, a volume problem, a laxity problem, a vascular problem or a pigment problem.

IF THE PROBLEM IS NOT PRIMARILY A RESURFACING PROBLEM, RESURFACING MAY NOT BE THE PRIMARY ANSWER.

Surface concerns involve texture, scars, lines and pigment. Movement concerns involve muscle. Volume concerns involve structural loss. Laxity concerns involve tissue position. Each category calls for a different treatment conversation. They are not interchangeable.

Wanting a treatment is not the same as having an indication. The concern should be identified before the device is selected. A patient who arrives asking for CO2 may or may not have a concern that CO2 addresses. Diagnosis first, device second.

CHOOSE THE PROBLEM BEFORE THE PRODUCT.

Baseline skin, phototype, PIH history, melasma, recent UV exposure and healing history all affect candidacy. The skin test asks whether the skin can be appropriately treated, not whether the patient wants treatment.

No. Skin tone is one factor, not the whole assessment. Phototype, PIH history, healing and UV exposure all interact. A Fitzpatrick number is not the whole patient. No universal yes or no applies to any skin tone.

A FITZPATRICK NUMBER IS NOT THE WHOLE PATIENT.

Darker skin can be considered for fractional CO2 resurfacing. Candidacy depends on individual assessment of phototype, PIH history, healing, concern and plan. No universal yes or no applies. Individualized clinical assessment is required.

Fitzpatrick IV skin may be considered for fractional CO2. PIH risk, healing history and treatment parameters require individualized assessment. A phototype number does not automatically exclude or approve. The treating clinician assesses the whole patient.

Fitzpatrick V skin requires careful individualized assessment. PIH risk is a relevant consideration. Treatment may be considered when the concern, skin and plan align and the risk-benefit discussion is appropriate. No blanket approval or exclusion.

Fitzpatrick VI skin requires careful individualized assessment. PIH risk is a significant consideration. Treatment may be considered in select cases after thorough clinical evaluation. No blanket approval. The treating clinician determines candidacy.

A history of post-inflammatory hyperpigmentation is part of the present plan. If the skin has reacted with pigment after inflammation before, that response is relevant to how CO2 is discussed. PIH history does not automatically exclude, but it changes the risk-benefit conversation.

YOUR SKIN'S PAST RESPONSE IS PART OF THE PRESENT PLAN.

A history of melasma changes the risk-benefit discussion for ablative resurfacing. Melasma involves complex pigment biology that may react to inflammation. Whether CO2 is appropriate for a patient with melasma requires individualized clinical assessment.

A current tan affects the skin's baseline pigment. Tanned skin may carry different PIH risk. JOLA's actual policy on tanning before treatment should be confirmed directly with the practice. This article does not publish an unverified protocol.

Recent sun exposure from vacation affects the skin's current state. UV exposure before treatment is a relevant consideration. The appropriate interval between sun exposure and treatment should be discussed with the treating clinician.

Self-tanner alters the skin's surface color, which may affect how the skin is assessed and treated. JOLA's actual protocol for self-tanner before treatment should be confirmed directly with the practice. This article does not publish an unverified protocol.

How the skin heals is part of candidacy. History of keloids, hypertrophic scars, poor wound healing, active infection and irritated skin all affect whether resurfacing is appropriate. Healing history is medical history.

HOW DOES YOUR SKIN HEAL?

A history of keloid scarring is important medical history. Keloids involve excessive scar tissue beyond the original wound. Whether this history affects CO2 candidacy requires clinician evaluation. This article does not create a universal exclusion.

A history of hypertrophic scarring is relevant medical history. Hypertrophic scars are raised but stay within the wound boundary. Whether this history affects candidacy requires individualized clinician evaluation.

A history of poor or delayed wound healing is relevant to candidacy. Healing capacity affects recovery and outcome. This history should be disclosed and assessed by the treating clinician.

Active infection in the treatment area is a relevant safety assessment. Current infection may affect whether treatment is appropriate at this time. This is a clinical determination, not an online one.

Open wounds or significantly irritated skin in the treatment area require clinical assessment. Treatment may need to be postponed until the skin is appropriate. This is a clinical determination.

A history of cold sores (herpes simplex virus) is relevant medical history. Laser resurfacing may trigger a recurrence in the treatment area. Patients should disclose this history so the clinician can plan around it.

DISCLOSE THE HISTORY. LET THE CLINICIAN PLAN AROUND IT.

Eczema is a relevant skin condition. Whether CO2 resurfacing is appropriate for a patient with eczema requires individualized evaluation of the condition, location and severity. This is a clinical determination.

Psoriasis is a relevant skin condition. Whether CO2 resurfacing is appropriate for a patient with psoriasis requires individualized evaluation. Koebner phenomenon and disease activity may be considerations. This is a clinical determination.

Dermatitis is a relevant skin condition. Active dermatitis in the treatment area may affect timing. Whether and when treatment is appropriate requires individualized clinical evaluation.

Rosacea is a distinct diagnosis. Whether CO2 resurfacing is appropriate for a patient with rosacea requires individualized evaluation. Diagnosis is not the same as treatment indication. This is a clinical determination.

A laser consultation is still a medical history. Medications, medical conditions, prior treatments, healing issues and pregnancy or breastfeeding status are all relevant. The consultation is not a formality. It is a medical assessment.

A LASER CONSULTATION IS STILL A MEDICAL HISTORY.

Pregnancy is a relevant consideration. JOLA's current policy on treating pregnant patients should be confirmed directly with the practice. This article does not make sweeping medical claims beyond current clinical guidance.

Breastfeeding is a relevant consideration. JOLA's current policy on treating breastfeeding patients should be confirmed directly with the practice. This article does not invent restrictions.

Historical guidance regarding isotretinoin and ablative laser timing has evolved. Treatment type, individual risk assessment and current evidence all matter. This article does not repeat outdated universal waiting periods. Do not stop isotretinoin without the prescriber's guidance.

Topical retinoids may affect skin sensitivity. JOLA's actual instructions regarding retinoid use before and after treatment should be confirmed directly with the practice. This article does not publish an unverified protocol.

Blood thinners are prescription medication. Do not discontinue blood thinners for a cosmetic procedure without the prescriber's guidance. This information should be disclosed during medical intake so the clinician can plan appropriately.

NEVER STOP PRESCRIBED MEDICATION FOR A COSMETIC PROCEDURE WITHOUT THE PRESCRIBER'S GUIDANCE.

Immunosuppression may affect healing and infection risk. Whether CO2 resurfacing is appropriate for an immunosuppressed patient requires provider assessment of the individual situation.

Autoimmune conditions do not automatically exclude. Whether CO2 is appropriate for a patient with an autoimmune condition requires individualized assessment of the condition, medications and healing capacity. No blanket exclusion.

Diabetes may affect healing. Whether CO2 resurfacing is appropriate for a patient with diabetes requires individualized assessment of medical status, glycemic control and healing capacity. No blanket answer applies.

Active cancer treatment requires coordination with the treating oncology team. Whether and when aesthetic treatment is appropriate is a medical determination involving the treating team and the clinician.

Patients should bring a complete medication and supplement list to the consultation. Medications may affect healing, pigmentation or treatment response. This article does not create an exhaustive online contraindication list.

Photosensitizing medications may affect how the skin responds to light-based treatment. Disclosure matters. Do not create DIY medication cessation instructions. The treating clinician assesses the medication list.

Allergies to topicals, anesthetics, dressings or aftercare products are relevant. Patients should disclose known allergies during medical intake so the clinician can select appropriate products.

What would make this treatment worthwhile to the patient? The expectation test asks whether the desired result is something CO2 can responsibly deliver. Expectations are part of candidacy.

WHAT WOULD MAKE THIS WORTH IT TO YOU?

A patient who wants acne scars to look softer, smoother and less visible may have a realistic expectation. Improvement is a clinical direction. This is an appropriate goal for resurfacing in a well-matched candidate.

A patient who expects zero scars after CO2 does not have an expectation the treatment can responsibly deliver. Resurfacing improves scars. It does not eliminate them. This expectation gap can affect whether treatment is appropriate.

A patient who wants improved surface texture, smoothness and skin quality may have a realistic expectation. Texture is a direction CO2 can address in appropriately selected patients.

A patient who expects the skin to look filtered in real life does not have an expectation resurfacing can deliver. Filters are digital. Skin is physical. This gap is relevant to candidacy.

A patient who understands that results develop over time, that remodeling is a process and that the final result is not immediate may have a realistic expectation. Patience is part of candidacy.

A patient who needs a final result next week does not have an expectation that aligns with how resurfacing works. Healing and remodeling take time. This timeline mismatch can affect candidacy.

The same treatment can be appropriate for one expectation and inappropriate for another. A patient with realistic expectations may be a good candidate. A patient with the same concern but unrealistic expectations may not be.

THE SAME TREATMENT CAN BE APPROPRIATE FOR ONE EXPECTATION AND INAPPROPRIATE FOR ANOTHER.

Perfectionism is relevant to candidacy. No resurfacing procedure creates flawless skin. A patient whose satisfaction requires perfection may not be well served by any treatment. This is handled sensitively, not diagnostically.

Can the patient's life accommodate the recovery? CO2 involves visible healing, aftercare, sun avoidance and follow-up. The downtime test asks whether the recovery window fits the patient's life right now.

CAN YOUR LIFE ACCOMMODATE THE RECOVERY?

Planning CO2 before a wedding requires conservative timing. Do not give a universal number of days. The interval depends on treatment intensity, healing and the individual plan. Consultation determines the appropriate timeline.

Even more conservative framing applies. The patient is the subject of the photography. Do not plan recovery around the best-case timeline. Plan for the realistic window with buffer.

DO NOT PLAN YOUR RECOVERY AROUND THE BEST-CASE TIMELINE.

Vacation involves sun, swimming, heat and aftercare logistics. If the skin will not be fully recovered and protected before travel, timing may not make sense. The specific vacation and interval matter.

A beach vacation involves significant sun and water exposure. If the skin is not fully healed and able to tolerate sun protection measures, a beach vacation shortly after CO2 may be poor timing. Do not invent a universal interval.

Skiing involves UV reflection from snow, cold, wind and skin barrier considerations. These factors are relevant to recovery timing. Whether skiing fits the recovery window should be discussed with the clinician.

A work event involves social downtime. Visible healing may or may not be acceptable depending on the event and the patient's role. The interval between treatment and the event should be discussed.

Family photos involve the same considerations as any photographed event. The skin should be fully recovered before photography. Plan backward from the date with consultation and buffer.

The holidays involve events, photos and travel. Plan backward from the commitments. No universal interval applies. The appropriate timeline depends on the treatment plan and the patient's schedule.

Working from home may accommodate recovery more easily than in-person work. This is a practical consideration, not a medical one. Whether the patient can follow aftercare while working should be discussed.

Childcare after CO2 depends on the recovery stage, the children's ages and support available. Avoid a universal answer. Aftercare logistics should be discussed during consultation.

Exercise after CO2 involves sweat, heat and sun exposure considerations. JOLA's protocol for resuming exercise should be confirmed directly with the practice. This article does not publish an unverified timeline.

Can the patient protect the skin during healing? Sun avoidance and protection are critical after CO2. If the patient cannot limit UV exposure as directed, candidacy may be affected.

CAN YOU PROTECT THE SKIN DURING HEALING?

An outdoor job involves significant UV exposure. If the patient cannot adequately protect treated skin during healing, an outdoor job is a relevant candidacy consideration. Timing and protection strategy matter.

Athletes involve sweat, sun and recovery logistics. These factors do not automatically exclude. Whether CO2 fits an athlete's training and competition schedule requires individualized discussion. No blanket exclusion.

Runners involve sun exposure, sweat and outdoor training. These factors are relevant to recovery. Whether and when to schedule CO2 around running should be discussed with the clinician.

Golf involves extended UV exposure, particularly relevant in Dallas. If a golfer cannot protect treated skin during healing, timing or treatment may need to change. UV exposure is a candidacy factor.

Tennis and pickleball involve outdoor UV exposure and sweat. These factors are relevant to recovery timing. Whether the patient can accommodate sun protection during healing should be discussed.

Air travel is not automatically contraindicated. The relevant question is whether the patient can follow aftercare and access the provider if concerns arise while traveling. Travel logistics are part of timing.

How much downtime and risk is the patient willing to accept for the change they want? Risk tolerance is personal. A patient who wants significant change but cannot accept downtime or risk may need a different plan.

HOW MUCH DOWNTIME AND RISK ARE YOU WILLING TO ACCEPT FOR THE CHANGE YOU WANT?

If a patient has low downtime tolerance, a less intensive treatment, a staged plan or a different modality may make more sense. CO2 is not the only option. The right treatment matches the tolerance.

A patient who expects significant change but cannot accept downtime or risk is often presenting an impossible brief. High change, zero downtime and zero risk rarely coexist. This mismatch is a candidacy issue.

HIGH CHANGE. ZERO DOWNTIME. ZERO RISK. IS OFTEN AN IMPOSSIBLE BRIEF.

If the concern is surface quality, pigment or texture with lighter recovery, the non-ablative ULTRA laser may be a better match. Different mechanism, different recovery. No universal winner. The concern determines the match.

K-LUXE pairs XERF radiofrequency with ULTRA laser. If both structural firmness and surface quality are relevant, K-LUXE may be a different treatment architecture to consider. The combination depends on the individual plan.

If the primary concern is skin firmness rather than surface resurfacing, XERF radiofrequency may be a better match. Different mechanism, different target. The concern determines the device, not the other way around.

RF microneedling delivers radiofrequency through needles. For certain concerns involving texture, scars or laxity, this mechanism may be a better match. No universal winner. The mechanism and concern determine the match.

For certain texture or pigment concerns where ablative resurfacing is not the right approach, microneedling may be considered. Different mechanism, different recovery. The concern determines the match.

If the primary concern is movement, volume or facial harmony, injectables may be a better match. Neuromodulators address movement. Filler and biostimulators address volume. These are different conversations from resurfacing.

If the primary concern is significant structural laxity or tissue position, a surgical consultation may be more appropriate. Resurfacing does not reposition tissue. Do not diagnose. This is a clinical determination.

A consultation does not have to end with a procedure. If the concern does not warrant treatment, if the risk outweighs the benefit or if the patient is not ready, doing nothing is a valid plan.

A CONSULTATION DOES NOT HAVE TO END WITH A PROCEDURE.

eCO2 3D can be worthwhile when the concern is appropriate, expectations are realistic, the patient accepts the recovery and risk profile, and the anticipated benefit justifies the investment. It is not universally worth it. Worth depends on the match.

CO2 may be worth it for acne scars when scar morphology, skin type and healing capacity support resurfacing. Not every scar or every patient is the same. The worth-it question is individual.

CO2 may be worth it for fine lines and surface wrinkles when the concern is primarily surface-related. Deep wrinkles involving movement or volume may need a different plan. Worth depends on the specific line.

CO2 may improve the appearance of pores. It does not eliminate them. Whether pore improvement justifies the investment is a personal determination. Set realistic expectations before deciding.

CO2 may be worth it for texture when surface irregularity is the primary concern and the skin is appropriate for resurfacing. Texture improvement is a direction, not an endpoint. Worth depends on the individual.

Whether CO2 is worth it for sun damage depends on the specific findings. Pigment, texture and fine lines may respond differently. Not every sun-damage finding is a resurfacing finding. The specific concern determines worth.

Whether the downtime is worth it depends on the expected benefit relative to the recovery, risk and cost. This is a risk-benefit question, not a universal answer. The patient weighs the tradeoff with clinical guidance.

WORTH IT IS A RISK-BENEFIT QUESTION.

Whether the cost is worth it depends on the concern, the plan, the expected benefit and the patient's values. Cost is one factor in the worth-it calculus. Confirm pricing directly with JOLA. This article does not include unverified pricing.

Age does not make someone a candidate. Skin condition, concern, history and health determine candidacy. A 30-year-old with appropriate scarring may be a candidate. A 55-year-old without a resurfacing concern may not. Age is one factor, not the factor.

AGE DOES NOT MAKE YOU A CANDIDATE.

CO2 in the 20s is indication-driven. If appropriate scarring or photoaging is present, treatment may be considered. If the skin is healthy, there is no indication. Age alone does not create candidacy.

CO2 in the 30s follows the same principle. The concern determines the treatment, not the decade. Early photoaging or acne scarring may be relevant. Healthy skin without a resurfacing concern is not an indication.

CO2 in the 40s may address photoaging, fine lines or acne scars. The skin, history and risk profile are assessed individually. Age is context, not candidacy.

CO2 in the 50s may address deeper photoaging, texture or scarring. Skin quality, healing capacity and medical history are relevant. The assessment is individual.

CO2 in the 60s and beyond may be considered when skin condition, health and healing capacity support treatment. Medical history and skin quality matter more than age alone. No universal age cutoff.

There is no universal age that is too young. Candidacy depends on the concern, skin and plan. A young patient with appropriate scarring may be a candidate. A young patient without a resurfacing concern is not.

There is no universal age that is too old. Medical status, skin quality and healing capacity matter more than age alone. A healthy older patient with an appropriate concern may be a candidate.

Preventative CO2 for healthy skin is not automatically indicated. Do not treat a future problem as though it already exists. If the skin is healthy, there is no resurfacing concern to treat. Prevention is not the same as treatment.

DO NOT TREAT A FUTURE PROBLEM AS THOUGH IT ALREADY EXISTS.

No. Healthy skin without a resurfacing concern is not an indication for CO2. Treatment should follow a need, not a trend. If there is no concern to address, there is no treatment to plan.

Why is treatment being considered now? Is there a stable concern, appropriate timing, an adequate recovery window and a realistic objective? If the answer is trend, social pressure or a friend's result, the why-now question is unresolved.

A treatment trending on social media is not a clinical indication. Popularity is not diagnosis. The concern, skin and plan determine whether treatment is appropriate, not the algorithm.

POPULAR IS NOT A DIAGNOSIS.

A friend's positive experience is not a clinical indication. Different skin, different concern, different plan. What worked for one person may not be appropriate for another. The individual assessment determines the plan.

An influencer's treatment is not a clinical indication. Social media does not know your skin, your history or your concerns. The individual assessment determines the plan, not the feed.

Widespread adoption is not a clinical indication. Many people receiving a treatment does not make it appropriate for every person. The individual assessment determines the plan.

The algorithm does not know your skin. It does not know your phototype, your healing history, your medications or your concerns. Social media is not a consultation. It is not a diagnosis.

THE ALGORITHM DOES NOT KNOW YOUR SKIN.

An individualized consultation assesses concern, skin, history, risk, goals, timing and alternatives. If the provider selects a device before assessing the skin, the consultation may not be individualized.

If a provider recommends a specific laser before examining the skin, the planning is backwards. The concern and skin should guide the device. Device-first planning is a warning sign.

DEVICE-FIRST PLANNING IS BACKWARDS.

If every patient receives the same treatment regardless of concern, skin or history, the planning is not individualized. The plan should follow the patient, not a template.

If a provider does not discuss post-inflammatory hyperpigmentation risk, particularly for patients with relevant phototype or history, that is a warning sign. PIH is a relevant risk for many patients.

If a provider does not discuss recovery, aftercare, sun avoidance and follow-up, that is a warning sign. Downtime is part of the treatment. A consultation that skips it is incomplete.

No provider can guarantee a specific result. If a guarantee is offered, that is a warning sign. Improvement is the goal. Guarantees are not responsible medicine.

No treatment has zero risk. If a provider claims zero risk, that is a warning sign. Every treatment carries some risk. Understanding and accepting the risk profile is part of candidacy.

No resurfacing treatment removes all scars. If a provider promises scar elimination, that is a warning sign. Improvement is the goal. Elimination is not.

If a provider does not discuss alternatives to CO2, that is a warning sign. A high-quality consultation presents options, including other treatments and no treatment.

A provider who tells you CO2 may not be right for your concern is practicing responsible medicine. Saying no is not rejection. It is individualized planning.

"NO" CAN BE A HIGH-QUALITY TREATMENT PLAN.

A consultation should follow a sequence: concern, history, skin assessment, photography, goal, risk, options, recovery, expectations and plan. Each step informs the next. The plan follows the assessment, not the other way around.

Bring a medication list, a skincare list, prior treatment history, photos if relevant, an event and travel calendar, and questions. Preparation helps the clinician assess the full picture.

JOLA's actual process for whether to arrive without makeup should be confirmed directly with the practice. This article does not publish an unverified protocol.

Do not stop skincare unless JOLA's protocol instructs. This article does not publish an unverified protocol. Confirm instructions directly with the practice before the consultation.

If prior before/after photos document previous treatment response, they may be useful. They are not required. Bring what documents your treatment history.

Disclose cold sore history, PIH history, melasma, keloid or scarring history, prior lasers, recent tanning, medications, medical conditions and upcoming travel or events. Full disclosure enables safe planning.

A self-assessment asks: What specific concern do I want to change? Is it primarily surface? Am I expecting improvement or perfection? Can I accommodate recovery? Can I limit UV? Do I have PIH or melasma history? Have I had healing problems? Do I have active skin inflammation? Am I taking medications? Do I have an event soon? Would a different treatment match better? Have I been assessed in person?

THIS DOES NOT DETERMINE MEDICAL CANDIDACY.

The candidacy matrix considers concern match, pigment considerations, recovery capacity, expectation alignment and timing. Each is assessed individually. The matrix does not output a yes. It identifies areas to discuss with the JOLA provider.

The decision tree starts with: What are you trying to change? Then: Is it surface or movement, volume, laxity, vascular or pigment? Does CO2 match the mechanism? What is your pigment history? How does your skin heal? Any relevant medical history? Can you accommodate downtime? Can you manage UV? Is the expectation realistic? Is the timing appropriate? What are the alternatives? Clinical assessment.

THE DECISION ENDS WITH A PLAN. NOT NECESSARILY A LASER.

We do not need a perfect patient. We need an appropriate match. A good candidate is someone for whom the concern, skin, history, risk, downtime, expectation and timing align. Perfection is not required. Alignment is.

WE DO NOT NEED A PERFECT PATIENT. WE NEED AN APPROPRIATE MATCH.

Not now does not always mean never. Timing, active skin issues, recent UV, upcoming events, medical review or the need to stabilize another concern may delay treatment. Temporary factors do not universally resolve candidacy.

Not now means timing. Not this treatment means mechanism mismatch. Not this intensity means plan issue. Not without medical review means history issue. Each no has a different meaning and a different path forward.

"NO" HAS MORE THAN ONE MEANING.

If CO2 is not the right treatment, that does not mean there is no answer. The appropriate plan may involve a different modality, a staged approach, skincare or no treatment. The goal is the right plan, not the specific device.

The non-ablative ULTRA laser may be an alternative when surface quality, pigment or texture is the concern and lighter recovery is preferred. Verified claims only. Different mechanism, different recovery profile.

K-LUXE pairs XERF radiofrequency with ULTRA laser. If both structural and surface concerns are relevant, K-LUXE may be an alternative framework. The combination depends on the individual plan.

XERF radiofrequency may be an alternative when the primary concern is skin firmness rather than surface resurfacing. Different mechanism, different target. The concern determines the match.

Microneedling may be an alternative for certain texture or pigment concerns where ablative resurfacing is not the right approach. Different mechanism, different recovery.

RF microneedling may be an alternative for certain concerns involving texture, scars or laxity. Different mechanism from CO2. The concern and skin determine the match.